메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Trends in decline of antiretroviral resistance among ARV-experienced patients in the HIV outpatient study: 1999-2008

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84873845936     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/230290     Document Type: Article
Times cited : (12)

References (29)
  • 3
    • 55249094827 scopus 로고    scopus 로고
    • Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study
    • 2-s2.0-55249094827 10.1097/QAD.0b013e328310e04f
    • Cozzi-Lepri A., Phillips A. N., Clotet B., Mocroft A., Ruiz L., Kirk O., Lazzarin A., Wiercinska-Drapalo A., Karlsson A., Lundgren J. D., Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. AIDS 2008 22 16 2187 2198 2-s2.0-55249094827 10.1097/QAD.0b013e328310e04f
    • (2008) AIDS , vol.22 , Issue.16 , pp. 2187-2198
    • Cozzi-Lepri, A.1    Phillips, A.N.2    Clotet, B.3    Mocroft, A.4    Ruiz, L.5    Kirk, O.6    Lazzarin, A.7    Wiercinska-Drapalo, A.8    Karlsson, A.9    Lundgren, J.D.10
  • 4
    • 36549034745 scopus 로고    scopus 로고
    • Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: An observational cohort study
    • DOI 10.1016/S0140-6736(07)61815-7, PII S0140673607618157
    • Phillips A. N., Leen C., Wilson A., Anderson J., Dunn D., Schwenk A., Orkin C., Hill T., Fisher M., Walsh J., Pillay D., Bansi L., Gazzard B., Easterbrook P., Gilson R., Johnson M., Sabin C. A., Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study. The Lancet 2007 370 9603 1923 1928 2-s2.0-36549034745 10.1016/S0140-6736(07)61815-7 (Pubitemid 350193334)
    • (2007) Lancet , vol.370 , Issue.9603 , pp. 1923-1928
    • Phillips, A.N.1    Leen, C.2    Wilson, A.3    Anderson, J.4    Dunn, D.5    Schwenk, A.6    Orkin, C.7    Hill, T.8    Fisher, M.9    Walsh, J.10    Pillay, D.11    Bansi, L.12    Gazzard, B.13    Easterbrook, P.14    Gilson, R.15    Johnson, M.16    Sabin, C.A.17
  • 5
    • 33749021387 scopus 로고    scopus 로고
    • Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART
    • DOI 10.1371/journal.pmed.0030356
    • Hogg R. S., Bangsberg D. R., Lima V. D., Alexander C., Bonner S., Yip B., Wood E., Dong W. W. Y., Montaner J. S. G., Harrigan P. R., Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Medicine 2006 3 9 2-s2.0-33749021387 10.1371/journal.pmed. 0030356 e356 (Pubitemid 44455267)
    • (2006) PLoS Medicine , vol.3 , Issue.9 , pp. 1570-1578
    • Hogg, R.S.1    Bangsberg, D.R.2    Lima, V.D.3    Alexander, C.4    Bonner, S.5    Yip, B.6    Wood, E.7    Dong, W.W.Y.8    Montaner, J.S.G.9    Harrigan, P.R.10
  • 6
    • 3843122021 scopus 로고    scopus 로고
    • Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing
    • DOI 10.1097/01.aids.0000131339.68666.1a
    • Lucas G. M., Gallant J. E., Moore R. D., Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing. AIDS 2004 18 11 1539 1548 2-s2.0-3843122021 10.1097/01.aids.0000131339.68666.1a (Pubitemid 39037478)
    • (2004) AIDS , vol.18 , Issue.11 , pp. 1539-1548
    • Lucas, G.M.1    Gallant, J.E.2    Moore, R.D.3
  • 9
    • 7744231500 scopus 로고    scopus 로고
    • Limited benefit of antiretroviral resistance testing in treatment-experienced patients: A meta-analysis
    • DOI 10.1097/00002030-200411050-00007
    • Panidou E. T., Trikalinos T. A., Ioannidis J. P. A., Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis. AIDS 2004 18 16 2153 2161 2-s2.0-7744231500 10.1097/00002030- 200411050-00007 (Pubitemid 39463680)
    • (2004) AIDS , vol.18 , Issue.16 , pp. 2153-2161
    • Panidou, E.T.1    Trikalinos, T.A.2    Ioannidis, J.P.A.3
  • 11
    • 0037083803 scopus 로고    scopus 로고
    • Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: A randomized study (Argenta)
    • DOI 10.1097/00002030-200202150-00008
    • Cingolani A., Antinori A., Rizzo M. G., Murri R., Ammassari A., Baldini F., Di Giambenedetto S., Cauda R., De Luca A., Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (Argenta). AIDS 2002 16 3 369 379 2-s2.0-0037083803 10.1097/00002030-200202150-00008 (Pubitemid 34165368)
    • (2002) AIDS , vol.16 , Issue.3 , pp. 369-379
    • Cingolani, A.1    Antinori, A.2    Rizzo, M.G.3    Murri, R.4    Ammassari, A.5    Baldini, F.6    Di Giambenedetto, S.7    Cauda, R.8    De Luca, A.9
  • 12
    • 67651089497 scopus 로고    scopus 로고
    • The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: A cohort study
    • 2-s2.0-67651089497
    • Palella F. J. Jr., Armon C., Buchacz K., Cole S. R., Chmiel J. S., Novak R. M., Wood K., Moorman A. C., Brooks J. T., The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Annals of Internal Medicine 2009 151 2 73 84 2-s2.0-67651089497
    • (2009) Annals of Internal Medicine , vol.151 , Issue.2 , pp. 73-84
    • Palella Jr., F.J.1    Armon, C.2    Buchacz, K.3    Cole, S.R.4    Chmiel, J.S.5    Novak, R.M.6    Wood, K.7    Moorman, A.C.8    Brooks, J.T.9
  • 16
    • 77950229001 scopus 로고    scopus 로고
    • Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. Patients, 1999 to 2006
    • 2-s2.0-77950229001 10.1097/QAI.0b013e3181bf1dd2
    • Buchacz K., Baker R. K., Young B., Brooks J. T., Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. Patients, 1999 to 2006. Journal of Acquired Immune Deficiency Syndromes 2010 53 5 625 632 2-s2.0-77950229001 10.1097/QAI.0b013e3181bf1dd2
    • (2010) Journal of Acquired Immune Deficiency Syndromes , vol.53 , Issue.5 , pp. 625-632
    • Buchacz, K.1    Baker, R.K.2    Young, B.3    Brooks, J.T.4
  • 18
    • 46349091980 scopus 로고    scopus 로고
    • Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy
    • DOI 10.1086/588675
    • Lima V. D., Gill V. S., Yip B., Hogg R. S., Montaner J. S. G., Harrigan P. R., Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy. Journal of Infectious Diseases 2008 198 1 51 58 2-s2.0-46349091980 10.1086/588675 (Pubitemid 351920289)
    • (2008) Journal of Infectious Diseases , vol.198 , Issue.1 , pp. 51-58
    • Lima, V.D.1    Gill, V.S.2    Yip, B.3    Hogg, R.S.4    Montaner, J.S.G.5    Harrigan, P.R.6
  • 19
    • 72049086981 scopus 로고    scopus 로고
    • Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection
    • 2-s2.0-72049086981 10.1086/648729
    • Gill V. S., Lima V. D., Zhang W., Wynhoven B., Yip B., Hogg R. S., Montaner J. S. G., Harrigan P. R., Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases 2010 50 1 98 105 2-s2.0-72049086981 10.1086/648729
    • (2010) Clinical Infectious Diseases , vol.50 , Issue.1 , pp. 98-105
    • Gill, V.S.1    Lima, V.D.2    Zhang, W.3    Wynhoven, B.4    Yip, B.5    Hogg, R.S.6    Montaner, J.S.G.7    Harrigan, P.R.8
  • 20
    • 72249107557 scopus 로고    scopus 로고
    • The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: A nationwide population-based Danish cohort study 1999-2005
    • 2-s2.0-72249107557 10.3851/IMP1412
    • Audelin A. M., Lohse N., Obel N., Gerstoft J., Jorgensen L. B., The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005. Antiviral Therapy 2009 14 7 995 1000 2-s2.0-72249107557 10.3851/IMP1412
    • (2009) Antiviral Therapy , vol.14 , Issue.7 , pp. 995-1000
    • Audelin, A.M.1    Lohse, N.2    Obel, N.3    Gerstoft, J.4    Jorgensen, L.B.5
  • 21
    • 67449097569 scopus 로고    scopus 로고
    • Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: A systematic review and meta-analysis
    • 2-s2.0-67449097569 10.1016/S1473-3099(09)70136-7
    • Gupta R. K., Hill A., Sawyer A. W., Cozzi-Lepri A., von Wyl V., Yerly S., Lima V. D., Günthard H. F., Gilks C., Pillay D., Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. The Lancet Infectious Diseases 2009 9 7 409 417 2-s2.0-67449097569 10.1016/S1473-3099(09)70136-7
    • (2009) The Lancet Infectious Diseases , vol.9 , Issue.7 , pp. 409-417
    • Gupta, R.K.1    Hill, A.2    Sawyer, A.W.3    Cozzi-Lepri, A.4    Von Wyl, V.5    Yerly, S.6    Lima, V.D.7    Günthard, H.F.8    Gilks, C.9    Pillay, D.10
  • 23
    • 3142660152 scopus 로고    scopus 로고
    • The prevalence of antiretroviral drug resistance in the United States
    • DOI 10.1097/01.aids.0000131310.52526.c7
    • Richman D. D., Morton S. C., Wrin T., Hellmann N., Berry S., Shapiro M. F., Bozzette S. A., The prevalence of antiretroviral drug resistance in the United States. AIDS 2004 18 10 1393 1401 2-s2.0-3142660152 10.1097/01.aids. 0000131310.52526.c7 (Pubitemid 38925131)
    • (2004) AIDS , vol.18 , Issue.10 , pp. 1393-1401
    • Richman, D.D.1    Morton, S.C.2    Wrin, T.3    Hellmann, N.4    Berry, S.5    Shapiro, M.F.6    Bozzette, S.A.7
  • 25
    • 34147143531 scopus 로고    scopus 로고
    • Triple-class antiretroviral drug resistance: Risk and predictors among HIV-1-infected patients
    • DOI 10.1097/QAD.0b013e32805e8764, PII 0000203020070423000005
    • Napravnik S., Keys J. R., Quinlivan E. B., Wohl D. A., Mikeal O. V., Eron J. J., Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS 2007 21 7 825 834 2-s2.0-34147143531 10.1097/QAD.0b013e32805e8764 (Pubitemid 46573154)
    • (2007) AIDS , vol.21 , Issue.7 , pp. 825-834
    • Napravnik, S.1    Keys, J.R.2    Quinlivan, E.B.3    Wohl, D.A.4    Mikeal, O.V.5    Eron Jr., J.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.